Analysis of the risk factors for influenza A (H1N1) pneumonia
- Authors:
- Qing Zhang
- Zhi‑Wei Zhao
- Zhi‑Li Xing
- Bo Zhang
- Hong‑Fei Zheng
- Li‑Xin Sun
View Affiliations
Affiliations: Department of Respiratory Disease, The Affiliated Hospital of Chengde Medical College, Chengde, Hebei 067000, P.R. China, Department of Emergency, The Affiliated Hospital of Chengde Medical College, Chengde, Hebei 067000, P.R. China, Central Laboratory, The Affiliated Hospital of Chengde Medical College, Chengde, Hebei 067000, P.R. China
- Published online on: June 3, 2013 https://doi.org/10.3892/br.2013.128
-
Pages:
723-726
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Pneumonia is the most common complication of influenza A (H1N1). However, there has been no identification of any single initial symptom as an independent risk factor. in 2009, 206 patients were diagnosed with H1N1 in the Chengde area, China and they were assembled in the Chengde Hospital for Infectious Diseases. The diagnosis and treatment were performed in accordance with the Protocol for Diagnosis and Treatment of Influenza A (H1N1) (2009, third edition), issued by the General Office of the Ministry of Health, with detailed records by the medical staff assigned by the Bureau of Health of the Chengde government. all the patients had viral nucleic acid‑positive throat swabs detected with quantitative reverse transcription polymerase chain reaction (qPCR). Based on the final imaging findings, patients were divided into the pneumonia and non‑pneumonia groups for this case control study. The univariate analysis demonstrated that the ratios of patients aged 0‑5 and ≥45 years, with underlying diseases, with initial symptoms including cough, expectoration and dyspnea and with onset‑to‑treatment interval of >48 h were higher in the pneumonia compared to the non‑pneumonia group (P<0.001, P<0.001, P=0.018, P<0.001, P<0.001 and P<0.001, respectively). The multivariate logistic regression analysis demonstrated that age 0‑5 years, presence of underlying diseases, expectoration as the initial symptom and onset‑to‑treatment interval of >48 h were the independent risk factors for pneumonia with relative odds ratios (OR) and 95% confidence intervals (95% CIs) of 6.120 and 1.779‑21.088, 11.188 and 2.021‑61.935, 5.263 and 2.042‑13.562, and 22.873 and 6.110‑85.631, respectively (P<0.01). Therefore, it is recommended that patients with H1N1 presenting with expectoration as the initial symptom be treated with caution during influenza pandemics.
View References
|
1
|
No authors listed. New influenza A (H1N1)
virus: global epidemiological situation. June;2009. Wkly Epidemiol
Rec. 84:249–257. 2009.PubMed/NCBI
|
|
2
|
Writing Committee of the WHO Consultation
on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Bautista E,
Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR,
Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C and
Nicholson KG: Clinical aspects of pandemic 2009 influenza A (H1N1)
virus infection. N Engl J Med. 362:1708–1719. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
World Health Organization. Pandemic (H1N1)
2009-update 112 [EB/OL]. http://www.who.int/csr/don/2010_08_06/en/uri.
Accessed October 13, 2009
|
|
4
|
General Office of the Ministry of Health.
Program of diagnosis and treatment of influenza A H1N1 (Version
III, 2009) [EB/OL]. http://news.xinhuanet.com/health/2009-11/11/content_12431885_3.htmuri.
Accessed October 13, 2009(In Chinese).
|
|
5
|
Trifonov V, Khiabanian H and Rabadan R:
Geographic dependence, surveillance, and origins of the 2009
influenza A (H1N1) virus. N Engl J Med. 361:115–119. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hancock K, Veguilla V, Lu X, Zhong W,
Butler EN, et al: Cross-reactive antibody responses to the 2009
pandemic H1N1 influenza virus. N Engl J Med. 361:1945–1952. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Webb SA, Pettilä V, Seppelt I, et al;
ANZIC Influenza Investigators. Critical care services and 2009 H1N1
influenza in Australia and New Zealand. N Engl J Med.
361:1925–1934. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumar A, Zarychanski R, Pinto R, et al:
Critically ill patients with 2009 influenza A (H1N1) infection in
Canada. JAMA. 302:1872–1879. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Louie JK, Aeosta M, Willter K, et al:
Factors associated with death or hospitalization due to pandemic
2009 influenza A (H1N1) infection in Califomia. JAMA.
302:1896–1902. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Van Kerkhove MD, Vandemaele KA, Shinde V,
Jaramillo-Gutierrez G, Koukounari A, et al: Risk factors for severe
outcomes following 2009 influenza A (H1N1) infection: a global
pooled analysis. PLoS Med. 8:e10010532011.PubMed/NCBI
|
|
11
|
Jain S, Kamimoto L, Bramley AM, Schmitz
AM, Benoit SR, et al: Hospitalized patients with 2009 H1N1
influenza in the United States, April-June 2009. N Engl J Med.
361:1935–1944. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Echevarría Zuno S, Mejía-Aranguré JM,
Mar-Obeso AJ, et al: Infection and death from influenza A H1N1
virus in Mexico: a retrospective analysis. Lancet. 374:2072–2079.
2009.PubMed/NCBI
|
|
13
|
Higuera Iglesias AL, Kudo K, Manabe T,
Corcho Berdugo AE, Corrales Baeza AC, et al: Reducing occurrence
and severity of pneumonia due to pandemic H1N1 2009 by early
oseltamivir administration: a retrospective study in Mexico. PLoS
One. 6:e218382011.PubMed/NCBI
|
